- Home
- MLGO vs BOLT Comparison
MLGO vs BOLT Comparison
Compare MLGO & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- BOLT
- Stock Information
- Founded
- MLGO 2018
- BOLT 2015
- Country
- MLGO China
- BOLT United States
- Employees
- MLGO N/A
- BOLT N/A
- Industry
- MLGO EDP Services
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- MLGO Technology
- BOLT Health Care
- Exchange
- MLGO Nasdaq
- BOLT Nasdaq
- Market Cap
- MLGO 15.6M
- BOLT 16.8M
- IPO Year
- MLGO N/A
- BOLT 2021
- Fundamental
- Price
- MLGO $14.66
- BOLT $5.63
- Analyst Decision
- MLGO
- BOLT Buy
- Analyst Count
- MLGO 0
- BOLT 3
- Target Price
- MLGO N/A
- BOLT $50.00
- AVG Volume (30 Days)
- MLGO 33.0M
- BOLT 19.4K
- Earning Date
- MLGO 04-28-2025
- BOLT 08-12-2025
- Dividend Yield
- MLGO N/A
- BOLT N/A
- EPS Growth
- MLGO N/A
- BOLT N/A
- EPS
- MLGO 16.40
- BOLT N/A
- Revenue
- MLGO $74,185,505.00
- BOLT $3,638,000.00
- Revenue This Year
- MLGO N/A
- BOLT N/A
- Revenue Next Year
- MLGO N/A
- BOLT $24.14
- P/E Ratio
- MLGO $1.08
- BOLT N/A
- Revenue Growth
- MLGO N/A
- BOLT N/A
- 52 Week Low
- MLGO $0.50
- BOLT $5.20
- 52 Week High
- MLGO $59.40
- BOLT $15.60
- Technical
- Relative Strength Index (RSI)
- MLGO 32.95
- BOLT 43.75
- Support Level
- MLGO $18.00
- BOLT $5.62
- Resistance Level
- MLGO $26.40
- BOLT $6.40
- Average True Range (ATR)
- MLGO 3.16
- BOLT 0.29
- MACD
- MLGO 2.76
- BOLT 0.01
- Stochastic Oscillator
- MLGO 7.56
- BOLT 25.00
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.